GeneCentric, a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at the American Association for ...

Inspira entered into a non-binding term sheet, outlining the principal terms of a proposed two-part transaction that would include the acquisition of an advanced liquid biopsy diagnostics business, ...

Vanderbilt researchers found that repeated liquid biopsies can predict how breast cancer patients respond to immunotherapy.

RA'ANANA, Israel, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, ...

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing challenge of simultaneously achieving high sensitivity, broad coverage, and simple ...

LAFAYETTE, La. (KLFY) — Our Lady of Lourdes is now offering patients the latest in lung cancer treatment using AI. The new artificial intelligence-based software and robot-assisted biopsy technology ...

CAMPBELL, Calif.--(BUSINESS WIRE)--Body Vision Medical, a leader in AI-driven, intraoperative image guidance, today announced that its LungVision® system has been selected as the winner of the “Best ...

The ArteraAI prostate biopsy assay predicts the risk of prostate cancer progression.

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022. Early detection plays a crucial role in reducing cancer-related morbidity and ...

Novel research in The Journal of Molecular Diagnostics details the new method, Bridge Capture, which advances cancer diagnostics and monitoring via liquid biopsies. The cell-free DNA isolated from ...